Sandrine Hulot

Sandrine Hulot, PhD has worked in a variety of roles in the biotechnology and pharmaceuticals industries since 2004. From 2004-2006, they were a Research Fellow at Massachusetts General Hospital, where they identified novel activators and inhibitors of Notch signaling through high throughput screens and dissected the Notch signaling pathway and its relevance for cell differentiation and carcinogenesis. In 2006, they became a Postdoctoral Research Scientist at Beth Israel Deaconess Medical Center, where they evaluated the immunogenicity of HIV vaccines in nonhuman primates in parallel of clinical trials in Humans. From 2013-2014, they worked as a Scientist in Biotechnology and Pharmaceuticals at From Academia to Industry, where they led a project on Immunotherapy through TCR in collaboration with a data mining startup. During this time, they also served as a Conseiller Consulaire de Nouvelle Angleterre at the Ministry of Foreign Affairs and International Development, interacting with the Consul General and their team in Boston, as well as the Congressman and Senators in Paris representing French citizens living abroad. In 2014, they also began working as a Postdoctoral Research Associate at Sanofi. From 2014-2017, they were a Catalyst promoting International Collaborations / Strategic Alliances at various Diverse Non Profit Organizations, such as French American Biotech Springboard (FABS) and Young Entrepreneurs Initiative (YEI) program. In 2017, they began working as a Scientist II at Cue Biopharma.

Sandrine Hulot, PhD obtained their Master's degree (Maitrise) in Biology from Pierre and Marie Curie University between 1999 and 2002. Sandrine then went on to pursue a Master's degree in Life sciences and Biotechnology (BioEngineering) from Conservatoire National des Arts et Métiers between 2002 and 2005. Finally, they completed their PhD in Biology from Conservatoire National des Arts et Métiers in 2010.